title: HHV-8 DNA sequences in the peripheral blood and skin lesions of an HIV-negative patient with multiple eruptive dermatofibromas: implications for the detection of HHV-8 as a diagnostic marker for Kaposi's sarcoma.
abstract: BACKGROUND
  Multiple eruptive dermatofibroma (MEDF) is a rare disorder seen in immunocompromised patients, simulating Kaposi's sarcoma (KS). Whereas KS is strongly associated with human herpesvirus 8 (HHV-8), the virus has never been detected in MEDF until now.
  
  
  OBJECTIVE
  To present a patient with MEDF who showed no signs of immunodeficiency but was seropositive for HHV-8 antibodies and demonstrated HHV-8 DNA both in the peripheral blood and lesional skin of MEDF.
  
  
  METHODS
  Clinical, histological and serological investigations were performed as well as polymerase chain reaction (PCR) studies and in situ hybridization (ISH).
  
  
  RESULTS
  A 35-year-old white man with suspected KS was referred for evaluation of multiple pigmented nodules and patches. Biopsies revealed features of dermatofibroma, superficial fibrosing dermatitis and scar. One of the nodular lesions harbored HHV-8 DNA sequences. A faint amplification product was detected in the superficial fibrosing dermatitis lesion, while no HHV-8 sequences were found in normal skin and scar. Whole-blood samples and serum were positive for HHV-8. None of the skin lesions shown to harbor HHV-8 DNA sequences by nested PCR displayed a signal for HHV-8 RNA by ISH. Repetitive peripheral blood examinations did not reveal any serum antibodies against or antigens of HIV. Serum antibodies against the HHV-8 capsid antigen orf 65.2 were detected.
  
  
  CONCLUSIONS
  Results of PCR studies and ISH indicate that the presence of HHV-8 in the lesional tissue was probably blood-borne due to viremia and not due to viral replication in tumor cells. The presence of HHV-8 is not fully restricted to KS. The differential diagnosis of KS and its simulators should be based on an integrative analysis of all available clinicopathological and molecular data and should not rely exclusively or predominantly on the presence or absence of HHV-8.
authors.affiliation: Department of Dermatology, University Hospital, Zurich, Switzerland.
authors.forename: D V
authors.initials: DV
authors.lastname: Kazakov
authors.forename: M
authors.initials: M
authors.lastname: Schmid
authors.forename: V
authors.initials: V
authors.lastname: Adams
authors.forename: G
authors.initials: G
authors.lastname: Cathomas
authors.forename: B
authors.initials: B
authors.lastname: Müller
authors.forename: G
authors.initials: G
authors.lastname: Burg
authors.forename: W
authors.initials: W
authors.lastname: Kempf
mesh_terms: D000328:Adult; D018952:Antigens, CD34; D004279:DNA, Viral / Q000032:analysis* / Q000097:blood; D003937:Diagnosis, Differential; D018023:HIV Seronegativity; D019288:Herpesvirus 8, Human / Q000235:genetics / Q000302:isolation & purification*; D018219:Histiocytoma, Benign Fibrous / Q000175:diagnosis* / Q000821:virology; D006801:Humans; D008297:Male; D016133:Polymerase Chain Reaction; D012514:Sarcoma, Kaposi / Q000175:diagnosis* / Q000821:virology; D012867:Skin / Q000473:pathology / Q000821:virology*; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000821:virology
chemical_list: D018952:Antigens, CD34; D004279:DNA, Viral